Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988;66(1):47-55.

Antigenic heterogeneity within influenza A (H3N2) virus strains

Antigenic heterogeneity within influenza A (H3N2) virus strains

J C de Jong et al. Bull World Health Organ. 1988.

Abstract

On the basis of their antigenic properties, influenza virus strains are classified into types and subtypes, which are further subdivided into variants that differ to various degrees in haemagglutination-inhibition assays. Evidence is presented that during infection with an influenza A(H3N2) virus the respiratory tract of a human patient often harbours more than one antigenic virus variant. These variants are frequently propagated by embryonated fowl eggs and monkey cells with different efficiencies, and this may lead to the selection of different variants by either of these host systems. Also, passage of virus by a given host is sometimes attended by changes in reactivity in haemagglutination-inhibition tests. In some cases the heterogeneity described also affects the specific immunogenicity of the virus in ferrets. Virus strains cloned in monkey kidney cell cultures gave variants that were stable upon further passage. These results may have implications for antigenic and biochemical investigations of epidemiologically relevant virus variants. It is argued that the antigenic drift of influenza A(H3N2) viruses is best characterized by analyses, both with post-infection ferret antisera and with panels of monoclonal antibodies, of virus strains isolated and passaged in monkey kidney cell cultures only.

PubMed Disclaimer

References

    1. Immunochemistry. 1978 Jul;15(7):429-36 - PubMed
    1. Arch Virol. 1985;86(3-4):253-62 - PubMed
    1. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4527-31 - PubMed
    1. Bull World Health Organ. 1973;48(2):199-202 - PubMed
    1. Am J Hyg. 1958 Sep;68(2):156-68 - PubMed

Substances

LinkOut - more resources